WINCHESTER, Mass.--(BUSINESS WIRE)--CardiAQ Valve Technologies (CVT), which is developing the world’s first self-conforming and self-anchoring technology for Transcatheter Mitral Valve Implantation (TMVI), today announced that it has elected Rob Michiels to serve on its Board of Directors, effective immediately. Until April 2009, Michiels was Chief Operating Officer at CoreValve, which was acquired by Medtronic for $700 million plus milestone payments.
